These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15206530)

  • 1. Multiple testing of noninferiority hypotheses in active controlled trials.
    Hung HM; Wang SJ
    J Biopharm Stat; 2004 May; 14(2):327-35. PubMed ID: 15206530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed noninferiority margin and statistical tests in active controlled trials.
    Tsou HH; Hsiao CF; Chow SC; Yue L; Xu Y; Lee S
    J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y; Zhang J; Levenson M
    J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninferiority testing beyond simple two-sample comparison.
    Tsong Y; Chen WJ
    J Biopharm Stat; 2007; 17(2):289-308. PubMed ID: 17365225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
    Tsong Y; Zhang J
    J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous testing of noninferiority and superiority increases the false discovery rate.
    Ng TH
    J Biopharm Stat; 2007; 17(2):259-64. PubMed ID: 17365222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bootstrap-based test for establishing noninferiority in clinical trials.
    Chen M; Kianifard F; Dhar SK
    J Biopharm Stat; 2006 May; 16(3):357-63. PubMed ID: 16724490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues with statistical risks for testing methods in noninferiority trial without a placebo ARM.
    Hung HM; Wang SJ; O'Neill R
    J Biopharm Stat; 2007; 17(2):201-13. PubMed ID: 17365218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the Fieller-Hinkley distribution of the ratio of random variables in testing for noninferiority.
    Koti KM
    J Biopharm Stat; 2007; 17(2):215-28. PubMed ID: 17365219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test for the consistency of noninferiority from multiple clinical trials.
    Yan X; Wang MC; Su X
    J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical issues on objective, design, and analysis of noninferiority active-controlled clinical trial.
    Tsong Y; Wang SJ; Hung HM; Cui L
    J Biopharm Stat; 2003 Feb; 13(1):29-41. PubMed ID: 12635901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adjustment of the type I error rate in noninferiority trials with λ-margin approach: each of two different new drugs is approved with two independent trials with the same active control.
    Kang SH; Ryu Y
    J Biopharm Stat; 2011 May; 21(3):498-510. PubMed ID: 21442522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotheses and type I error in active-control noninferiority trials.
    Chen G; Wang YC; Chi GY
    J Biopharm Stat; 2004 May; 14(2):301-13. PubMed ID: 15206528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A covariate-adjustment regression model approach to noninferiority margin definition.
    Nie L; Soon G
    Stat Med; 2010 May; 29(10):1107-13. PubMed ID: 20209669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On non-inferiority analysis based on delta-method confidence intervals.
    Rothmann MD; Tsou HH
    J Biopharm Stat; 2003 Aug; 13(3):565-83. PubMed ID: 12921402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues of simultaneous tests for noninferiority and superiority.
    Ng TH
    J Biopharm Stat; 2003 Nov; 13(4):629-39; discussion 641-62. PubMed ID: 14584713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninferiority hypotheses and choice of noninferiority margin.
    Ng TH
    Stat Med; 2008 Nov; 27(26):5392-406. PubMed ID: 18680173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple comparisons and multiple contrasts in randomized dose-response trials--confidence interval oriented approaches.
    Hothorn LA
    J Biopharm Stat; 2006; 16(5):711-31. PubMed ID: 17037267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tests of noninferiority via rate difference for three-arm clinical trials with placebo.
    Tang ML; Tang NS
    J Biopharm Stat; 2004 May; 14(2):337-47. PubMed ID: 15206531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A ratio test in active control non-inferiority trials with a time-to-event endpoint.
    Wang YC; Chen G; Chi GY
    J Biopharm Stat; 2006; 16(2):151-64. PubMed ID: 16584064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.